Wang K, LiuW, Yan X-L, et al. Long-term postoperative survival prediction in patients with colorectal liver metastasis. Oncotarget. 2017;8:79927–79934.
Clavien P-A, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545–1559.
Petrowsky H, Fritsch R, Guckenberger M, et al. Modern therapeutic approaches for malignant liver tumours. Nat Rev Gastroenterol Hepatol. 2020 [published online ahead of print]. doi:10.1038/s41575-020-0314-8.
Clavien P-A, Oberkofler CE, Raptis DA, et al. What is critical for liver surgery and partial liver transplantation: Size or quality? Hepatology. 2010;52:715–729.
Clavien PA. Hepatic Vein Embolization for Safer Liver Surgery. Insignificant novelty or a breakthrough? Ann Surg. 2020;272:206–209.
Kron P, Linecker M, Jones RP, et al. Ablation or resection for colorectal liver metastases? A systematic review of the literature. Front Oncol. 2019;9:1052.
Dueland S, Syversveen T, Solheim JM, et al. Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases. Ann Surg. 2020;271:212–218.
Oberkofler CE, Hamming JF, Staiger RD, et al. Procedural surgical RCTs in daily practice: do surgeons adopt or is it just a waste of time? Ann Surg. 2019;270:727–734.
Aubin JM, Bressan AK, Grondin SC, et al. Assessing resectability of colorectal liver metastases: how do different subspecialties interpret the same data? Can J Surg. 2018;61:251–256.
Huiskens J, Bolhuis K, Engelbrecht MR, et al. Outcomes of respectability assessment of the Dutch colorectal cancer group liver metastases expert panel. J Am Coll Surg. 2019;229:523–532. e2.
Warrens MJ. Inequalities between multi-rater kappas. Adv Data Anal Classif. 2010;4:271–286.